Allergan, Inc. disclosed in its latest quarterly report on Form
10-Q filed with the U.S. Securities and Exchange Commission that
in July 2010, the Supreme Court of the State of California
reversed the Court of Appeal’s judgment and remanded the…
provides in-depth news coverage of pending and recently settled lawsuits involving public companies with assets of USD $1 billion or more. Covered litigation topics include tax issues, insurance disputes, labor problems, shareholder suits, antitrust suits, product liability suits, toxic torts, personal injury suits, among others.